Editorial: Understanding scleroderma: symptoms, causes, treatment options, and advanced diagnostic techniques. [PDF]
Ostojic P.
europepmc +1 more source
Long-Term Nonprogressive Interstitial Lung Disease in Anti-PL-12- and Anti-Ro52-Positive Antisynthetase Syndrome Without Immunosuppressive Therapy. [PDF]
Almaalouli B, Choula HR, Rodriguez M.
europepmc +1 more source
Single‑cell RNA sequencing reveals fibroblast heterogeneity and identifies CLOCK as a key regulator in fibrotic skin diseases. [PDF]
Li Y +8 more
europepmc +1 more source
Combination of Oral Hydroxychloroquine and Topical Pimecrolimus 1% for Linear Morphea in Breastfeeding: A Rare Case with Favorable Outcome. [PDF]
Suwarsa O +7 more
europepmc +1 more source
Ischemic Necrosis of Bilateral Second Toes in the Absence of Macrovascular Disease or Primary Vasculitis: A Unique Case of Systemic Sclerosis Sine Scleroderma (ssSSc). [PDF]
Elhaddad M +4 more
europepmc +1 more source
New Onset Scleroderma in Elderly Males-A Case Series-Based Review of the Literature. [PDF]
Kodesh A +4 more
europepmc +1 more source
Renal Vascular Affection in Systemic Sclerosis Patients and Possible Correlation with Peripheral Vascular Involvement Assessed by Nailfold Capillaroscopy. [PDF]
Samy N +5 more
europepmc +1 more source
Articular flare-up of systemic scleroderma revealing a rare form of tuberculosis of the shoulder and extensor tendons: a case report and literature review. [PDF]
Zouaki H +6 more
europepmc +1 more source
Related searches:
Scleroderma (systemic sclerosis) is a complex disease in which extensive fibrosis, vascular alterations, and autoantibodies against various cellular antigens are among the principal features There are two major subgroups in the commonly accepted classification of scleroderma: limited cutaneous scleroderma and diffuse cutaneous scleroderma.
Gabrielli A. +2 more
openaire +4 more sources

